Tushar Misra

Tushar Misra discloses dealings in Mersana Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 16 August 2022 to 16 January 2024, the count stands at 9 filings.

No open-market purchase appears, only 4 sales worth €26k. The rest of the record consists of 5 option exercises. In 2024 alone, the filings show no purchases and 1 sale.

Most recently, on 17 January 2024, the filings show an option exercise in Mersana Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.